These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6379568)

  • 1. [Comparison of serum and prostatic levels of tobramycin].
    Bismuth R; Fredj G; Khoury S; Rigat B
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):511-5. PubMed ID: 6379568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study of prostatic tissue levels of latamoxef, cefoperazone and cefotaxime].
    Takeuchi N; Kinukawa T; Matsuura O; Hattori R; Hasegawa S; Ohshima S; Ono Y
    Hinyokika Kiyo; 1986 Dec; 32(12):1831-41. PubMed ID: 2435132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diffusion of cefmenoxime into prostatic fluid in the patients with acute bacterial prostatitis].
    Katoh N; Sugiyama T; Ono Y; Hirabayashi S
    Hinyokika Kiyo; 1990 Nov; 36(11):1287-93. PubMed ID: 2288308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ceftazidime concentration in human prostatic tissue and serum following intravenous injection].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1991 Jun; 37(6):659-62. PubMed ID: 1716410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prostatic tissue levels of ceftizoxime].
    Hoshi S; Kimura M; Kuwahara M; Orikasa S; Nakano S; Chiba R; Ishii N; Kato M; Morita M; Kato H
    Hinyokika Kiyo; 1985 May; 31(5):863-70. PubMed ID: 3901702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Concentration level of latamoxef sodium (LMOX) in prostatic tissue].
    Takao M; Matsuzaki S; Ao T; Nagakura K; Fujioka T; Hata M; Nakamura H; Hayakawa M
    Hinyokika Kiyo; 1985 Mar; 31(3):539-43. PubMed ID: 2411116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostatic tissue levels of cefpiramide (CPM)].
    Takata K; Kawamura S; Yoshida I
    Hinyokika Kiyo; 1988 Jun; 34(6):1105-8. PubMed ID: 2464916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Passage of cefotiam into prostatic tissue].
    Charton M; Panis G; Brisset JM; Veillon B; Vallancien G; Selles JP
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):530-2. PubMed ID: 3911149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of an immunoassay and a microbiological assay for tobramycin serum concentrations.
    Fukuchi H; Yoshida M; Okihara M; Tokuoka S; Konishi T
    Am J Hosp Pharm; 1981 Dec; 38(12):1933-6. PubMed ID: 6798863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillin-aminoglycoside inactivation: another possible mechanism of interaction.
    Russo ME
    Am J Hosp Pharm; 1980 May; 37(5):702-4. PubMed ID: 7386483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of clarithromycin in the prostate: implications for the treatment of chronic abacterial prostatitis.
    Giannopoulos A; Koratzanis G; Giamarellos-Bourboulis EJ; Panou C; Adamakis I; Giamarellou H
    J Urol; 2001 Jan; 165(1):97-9. PubMed ID: 11125373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study on transfer of ceftizoxime into prostatic and vesical tissues].
    Katsumi T; Murayama K
    Hinyokika Kiyo; 1984 Feb; 30(2):259-64. PubMed ID: 6204521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum aminoglycoside monitoring by enzyme immunoassay, biological, and fluorescence immunoassay procedures.
    Buchanan AG; Witwicki E; Albritton WL
    Am J Med Technol; 1983 Jun; 49(6):437-41. PubMed ID: 6349357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobramycin dosing in the puerperal patient.
    Pastorek JG; Ragan FA; Phelan M
    J Reprod Med; 1987 May; 32(5):343-6. PubMed ID: 3598982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic tissue concentrations and serum levels of Myocamicin in human subjects.
    Fraschini F; Scaglione F; Cicchetti F; Rossi M; Borghi C; Alfano G; Maierna G; Balsamo V; Gattei G
    Drugs Exp Clin Res; 1988; 14(4):253-5. PubMed ID: 3262495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Astromicin sulfate concentration in human prostatic tissue after an intramuscular injection].
    Morita M; Hasuda A
    Hinyokika Kiyo; 1988 Oct; 34(10):1865-8. PubMed ID: 2469325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ofloxacin concentration in prostatic tissue].
    Kawauchi A; Kamoi K; Ohne T; Imada N; Kitamori T; Terasaki T; Watanabe H
    Hinyokika Kiyo; 1993 Dec; 39(12):1191-3. PubMed ID: 7506868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study of prostatic tissue levels of cefodizime (CDZM)].
    Yamada Y; Fukatsu H; Kamijo A; Mizumoto H; Taki T; Mitsui K; Nonomura H; Ohshita H; Miyagawa Y; Hatano Y
    Hinyokika Kiyo; 1994 Apr; 40(4):365-9. PubMed ID: 7514846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study of cefoperazone prostatic tissue levels: difference between the gland and capsule].
    Fukushima S; Miura T; Kondo I; Fujii H; Hirokawa M; Iwasaki A; Ishizuka E; Kitajima N
    Hinyokika Kiyo; 1983 Jan; 29(1):87-93. PubMed ID: 6203376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer.
    Nishiyama T; Hashimoto Y; Takahashi K
    Clin Cancer Res; 2004 Nov; 10(21):7121-6. PubMed ID: 15534082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.